SCHEMBL15317657

SCHEMBL15317657

CC(C)(C)c1ccc(C(=O)NCCCN2CCCC2)cc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.89
LMNA P02545 2/20 0.89
MAPT P10636 2/20 0.89
GAA P10253 1/20 0.89
MAPK1 P28482 1/20 0.89
HTT P42858 1/20 0.89
SMN1; SMN2 Q16637 1/20 0.89
KMT2A Q03164 2/20 0.65
MEN1 O00255 1/20 0.65
NPSR1 Q6W5P4 1/20 0.60
DRD2 P14416 1/20 0.59
DRD3 P35462 1/20 0.59
RECQL P46063 1/20 0.59
L3MBTL1 Q9Y468 2/20 0.58
L3MBTL3 Q96JM7 1/20 0.58
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
POLB P06746 1/20 0.56
TSHR P16473 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10202448 0.92 MEN1 (0.77) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL19226707 0.90 SMN1; SMN2 (0.92) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL12376590 0.90 MEN1 (0.75) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL13762069 0.88 ALDH1A1 (0.82) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL23139666 0.88 KMT2A (0.80) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL23666314 0.86 KMT2A (0.78) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL10194869 0.86 NPSR1 (0.81) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL5466382 0.85 EPHX2 (0.70) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL15317679 0.85 MAPT (0.65) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL13211930 0.84 NPSR1 (0.79) ALDH1A1LMNAMAPTGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 US disclosed
US-9073892-B2 Indazolyl triazol derivatives MERCK SERONO S.A. (CH) 2015-07-07 US disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 US disclosed
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES MERCK SERONO S.A. - INTELLECTUAL PROPERTY (CH) 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274241-A1 INDAZOLYL TRIAZOL DERIVATIVES NFATC1, IL5, CD4 ALDH1A1 875/4885LMNA 4562/4885MAPT 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.